DME Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$55.8M |
| 2 |
Viatris
VTRS
|
+$31.8M |
| 3 |
Capri Holdings
CPRI
|
+$24.8M |
| 4 |
Peloton Interactive
PTON
|
+$24.3M |
| 5 |
ODP
ODP
ODP
|
+$22.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$52M |
| 2 |
First Citizens BancShares
FCNCA
|
+$41.1M |
| 3 |
LivaNova
LIVN
|
+$39.2M |
| 4 |
Tenet Healthcare
THC
|
+$35.3M |
| 5 |
AerCap
AER
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 42.42% |
| 2 | Technology | 15.68% |
| 3 | Healthcare | 13.15% |
| 4 | Energy | 12.96% |
| 5 | Financials | 6.3% |
Similar funds
DME Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, DME Capital Management held 45 positions worth $2.04B, down 6.4% from $2.18B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
DME Capital Management withdrew a net $109M in Q2 2024, closing 6 positions and reducing 9 holdings. Its most notable exit was First Citizens BancShares, an estimated $41.1M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DME Capital Management opened a new position in Capri Holdings worth $22.7M.
- DME Capital Management's largest Q2 2024 buy was Capri Holdings: 684,770 shares worth $22.7M.
- DME Capital Management added most to HP in Q2 2024, an estimated $55.8M increase.
- DME Capital Management's biggest Q2 2024 reduction was Kyndryl, cutting an estimated $52M.
- DME Capital Management fully exited First Citizens BancShares in Q2 2024, selling an estimated $41.1M.
- DME Capital Management's ten largest holdings make up 76% of its $2.04B portfolio in Q2 2024.
- DME Capital Management opened 3 new positions and closed 6 in Q2 2024.
- DME Capital Management's portfolio value fell 6.4% quarter-over-quarter to $2.04B.
Based on DME Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.